Finance Fusion Network
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Finance Fusion Network
No Result
View All Result

Birkenstock’s quarterly revenue beats on resilient demand

by
December 18, 2024
in Investing
0
Birkenstock’s quarterly revenue beats on resilient demand

(Reuters) -Birkenstock beat market expectations for fourth-quarter revenue on Wednesday, helped by robust full-price sales of the German footwear maker’s pricey sandals in the United States and Asia.

With fresh styles becoming a priority for consumers, particularly in its largest market in the Americas, Birkenstock (NYSE:BIRK)’s sandals and close-toed clogs alike have drawn new customers to its stores.

This has also allowed the company to raise prices for clogs, which increased 8% in the fiscal year ended Sept. 30.

Birkenstock’s shares were marginally lower in premarket trading after the company forecast fiscal 2025 revenue growth below market expectations.

Shoppers have approached non-essential purchases with caution despite cooling inflation, carefully comparing prices, a trend also at play during the on-going holiday season.

This has resulted in some softness in expectations from retailers in the U.S. for 2025.

Birkenstock, which debuted on the New York Stock Exchange in October 2023, invested in expanding its store presence in markets such as Japan and China, as well as increasing its manufacturing capacity this year to meet global demand.

The company reported fourth-quarter revenue of 455.8 million euros ($478.27 million), compared with the average analyst estimate of 439.2 million euros, according to data compiled by LSEG.

Birkenstock expects fiscal 2025 revenue to grow between 15% and 17%, compared with estimates of 17.5% growth.

($1 = 0.9530 euros)

This post appeared first on investing.com
Previous Post

Renault open in principle to Nissan pursuing merger talks with Honda, sources say

Next Post

EU to review studies linking Novo Nordisk’s Ozempic to rare eye condition

Next Post
EU to review studies linking Novo Nordisk’s Ozempic to rare eye condition

EU to review studies linking Novo Nordisk’s Ozempic to rare eye condition

  • Trending
  • Comments
  • Latest
Elon Musk connects with indie Andrew Yang on billionaire former Trump ally’s third party push

Elon Musk connects with indie Andrew Yang on billionaire former Trump ally’s third party push

July 8, 2025
Analysis-To weather Trump, emerging market investors look to the frontier

Analysis-To weather Trump, emerging market investors look to the frontier

January 27, 2025
DAVID MARCUS: Public broadcasting’s purpose has passed. It’s time to pull the plug

DAVID MARCUS: Public broadcasting’s purpose has passed. It’s time to pull the plug

February 7, 2025
Over 158 million Americans voted in 2024 as Trump reclaimed the White House

Over 158 million Americans voted in 2024 as Trump reclaimed the White House

July 7, 2025
171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

0
Harris campaign officials explain what went wrong –  and what Trump did right: report

Harris campaign officials explain what went wrong – and what Trump did right: report

0
New Republican Governors Association chair says ‘focus’ is on helping Trump get ‘off to a strong start’

New Republican Governors Association chair says ‘focus’ is on helping Trump get ‘off to a strong start’

0
NVIDIA Corporation (NASDAQ:NVDA) shares fell roughly 3%

NVIDIA Corporation (NASDAQ:NVDA) shares fell roughly 3%

0
171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

March 11, 2026
FDA launches new AI-powered system to track drug and vaccine side effects nationwide

FDA launches new AI-powered system to track drug and vaccine side effects nationwide

March 11, 2026
Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

March 11, 2026
DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

March 11, 2026

    Fill Out & Get More Relevant News

    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent News

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    March 11, 2026
    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    March 11, 2026
    Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

    Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

    March 11, 2026
    DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

    DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him

    March 11, 2026

    Top News

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns

    March 11, 2026
    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    FDA launches new AI-powered system to track drug and vaccine side effects nationwide

    March 11, 2026

    Latest News

    • 171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns
    • FDA launches new AI-powered system to track drug and vaccine side effects nationwide
    • Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate

    About Finance Fusion Network

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 Financefusionnetwork.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Latest News
    • Editor’s Pick
    • Economy

    Copyright © 2024 Financefusionnetwork.com. All Rights Reserved.